Published June 5, 2026 | Version v1
Other Open

In malignant hypercalcaemia with low phosphate, low vitamin D, and low PTH, what should be replaced first? Denosumab was not given due to low phosphate.

Authors/Creators

  • 1. Tripdatabase

Description

In cases of malignant hypercalcemia with low phosphate, it may be prudent to correct phosphate levels prior to initiating treatments like denosumab, which could exacerbate hypophosphatemia.

Files

467cc849-be65-40cc-adb6-2a197364498b.pdf

Files (18.4 kB)

Name Size Download all
md5:18d712a777999f2a864c1e2e4099919e
18.4 kB Preview Download

Additional details